For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Did you know over eight million Nigerians are living with diabetes? Click and discover Inside Nigeria’s diabetes crisis: Lifestyle and more ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...